Leon R. McFarlane

579 total citations
8 papers, 207 citations indexed

About

Leon R. McFarlane is a scholar working on Immunology, Infectious Diseases and Rheumatology. According to data from OpenAlex, Leon R. McFarlane has authored 8 papers receiving a total of 207 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 2 papers in Infectious Diseases and 2 papers in Rheumatology. Recurrent topics in Leon R. McFarlane's work include SARS-CoV-2 and COVID-19 Research (2 papers), Immunotherapy and Immune Responses (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Leon R. McFarlane is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (2 papers), Immunotherapy and Immune Responses (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). Leon R. McFarlane collaborates with scholars based in United Kingdom, Denmark and Uganda. Leon R. McFarlane's co-authors include Tom Cole, Robin J. Shattock, Suzanne Day, Hannah M. Cheeseman, Anja Weinreich Olsen, Ingrid Kromann, Frank Follmann, David Lewis, Peter Andersen and Sonya Abraham and has published in prestigious journals such as Frontiers in Immunology, The Lancet Infectious Diseases and PLoS Pathogens.

In The Last Decade

Leon R. McFarlane

7 papers receiving 205 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leon R. McFarlane United Kingdom 7 86 81 66 40 29 8 207
Suzanne Day United Kingdom 6 87 1.0× 79 1.0× 65 1.0× 42 1.1× 50 1.7× 7 226
Teresa Kinyari Kenya 6 123 1.4× 69 0.9× 60 0.9× 14 0.3× 28 1.0× 8 223
Chun Tan United States 6 274 3.2× 65 0.8× 182 2.8× 63 1.6× 76 2.6× 7 343
Luca Schifanella United States 11 63 0.7× 98 1.2× 92 1.4× 92 2.3× 58 2.0× 21 343
Karen P. Demick United States 9 116 1.3× 197 2.4× 177 2.7× 36 0.9× 56 1.9× 9 410
Taylor B. Poston United States 10 234 2.7× 129 1.6× 131 2.0× 14 0.3× 26 0.9× 19 279
David Jose Delgado-Diaz Australia 4 196 2.3× 54 0.7× 118 1.8× 42 1.1× 101 3.5× 4 282
Filipe Almeida Portugal 10 163 1.9× 29 0.4× 128 1.9× 53 1.3× 67 2.3× 14 274
Päivi Joki‐Korpela Finland 10 112 1.3× 50 0.6× 172 2.6× 275 6.9× 50 1.7× 17 496
B. Ho Singapore 11 111 1.3× 72 0.9× 124 1.9× 69 1.7× 20 0.7× 16 335

Countries citing papers authored by Leon R. McFarlane

Since Specialization
Citations

This map shows the geographic impact of Leon R. McFarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leon R. McFarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leon R. McFarlane more than expected).

Fields of papers citing papers by Leon R. McFarlane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leon R. McFarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leon R. McFarlane. The network helps show where Leon R. McFarlane may publish in the future.

Co-authorship network of co-authors of Leon R. McFarlane

This figure shows the co-authorship network connecting the top 25 collaborators of Leon R. McFarlane. A scholar is included among the top collaborators of Leon R. McFarlane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leon R. McFarlane. Leon R. McFarlane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
2.
Day, Suzanne, Charandeep Kaur, Hannah M. Cheeseman, et al.. (2022). Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens. Frontiers in Immunology. 13. 991509–991509. 7 indexed citations
3.
Elliott, Tamara, Hannah M. Cheeseman, Abbey Evans, et al.. (2022). Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccines. PLoS Pathogens. 18(10). e1010885–e1010885. 15 indexed citations
4.
Abraham, Sonya, Helene Bæk Juel, Peter Fibiger Bang, et al.. (2019). Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Infectious Diseases. 19(10). 1091–1100. 135 indexed citations
5.
Guttery, David S., Jon K. Pittman, Karine Frénal, et al.. (2013). The Plasmodium berghei Ca2+/H+ Exchanger, PbCAX, Is Essential for Tolerance to Environmental Ca2+ during Sexual Development. PLoS Pathogens. 9(2). e1003191–e1003191. 29 indexed citations
6.
Pal, B., et al.. (1999). Is routine synovial fluid analysis necessary? Lessons and recommendations from an audit. Rheumatology International. 18(5-6). 181–182. 6 indexed citations
7.
Oppenheim, B., et al.. (1997). Routine synovial fluid culture: is it necessary? Lessons from an audit. Lara D. Veeken. 36(10). 1116–1117. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026